Atrial fibrillation (AF) is the most common sustained arrythmia and one of the strongest risk
factors and causal mechanisms of ischemic stroke (IS). Acute IS due to AF tends to be more …

Background: Although non-vitamin K antagonist oral anticoagulants (NOACs) are
recommended over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management …

Background The use of anticoagulants is an established strategy to prevent stroke,
embolism, and cardiovascular mortality in patients with atrial fibrillation (AF), but its role in …

Background and aim Current observational studies have compared the effectiveness and
safety of edoxaban with other oral anticoagulants in patients with AF, but the results are still …

Background Little is known how individual time-in-therapeutic-range (TTR) impacts the
effectiveness and safety of warfarin therapy compared to direct oral anticoagulants (DOACs) …

Background: Since the association of vitamin D with atrial fibrillation (AF) risk is still unclear,
we conducted this updated meta-analysis of prospective studies to identify the relationship …

Background: Several studies summarized the clinical performance of direct oral
anticoagulants (DOACs) in atrial fibrillation (AF) patients with mitral stenosis or aortic …

В монографии представлена фармакологическая характеристика современных
лекарственных средств, используемых при острых и хронических нарушениях …

Cerebral venous thrombosis (CVT) is a rare clotting disorder that mainly affects younger
females. In order to achieve recanalization of cerebral veins and reduce the risk of venous …